4//SEC Filing
MYLAN INC. 4
Accession 0001209191-15-019902
CIK 0000069499operating
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 6:40 PM ET
Size
22.9 KB
Accession
0001209191-15-019902
Insider Transaction Report
Form 4
MYLAN INC.MYL
Piatt Rodney L
Director
Transactions
- Disposition to Issuer
Common Stock
2015-02-27−33,135→ 0 total - Disposition to Issuer
Non-Employee Director Stock Option - Right to Buy
2015-02-27−19,994→ 0 totalExercise: $12.96Exp: 2018-04-25→ Common Stock (19,994 underlying) - Disposition to Issuer
Non-Employee Director Stock Option - Right to Buy
2015-02-27−14,286→ 0 totalExercise: $13.43Exp: 2019-05-07→ Common Stock (14,286 underlying) - Disposition to Issuer
Non-Employee Director Stock Option - Right to Buy
2015-02-27−11,626→ 0 totalExercise: $20.52Exp: 2020-05-14→ Common Stock (11,626 underlying) - Disposition to Issuer
Non-Employee Director Stock Option - Right to Buy
2015-02-27−10,864→ 0 totalExercise: $23.90Exp: 2021-05-06→ Common Stock (10,864 underlying) - Disposition to Issuer
Non-Employee Director Stock Option - Right to Buy
2015-02-27−13,158→ 0 totalExercise: $21.00Exp: 2022-05-04→ Common Stock (13,158 underlying) - Disposition to Issuer
Non-Employee Director Stock Option - Right to Buy
2015-02-27−6,623→ 0 totalExercise: $31.63Exp: 2023-05-28→ Common Stock (6,623 underlying) - Disposition to Issuer
Non-Employee Director Stock Option - Right to Buy
2015-02-27−2,974→ 0 totalExercise: $45.72Exp: 2024-04-11→ Common Stock (2,974 underlying)
Footnotes (11)
- [F1]On February 27, 2015 (the "Closing Date"), Mylan N.V. completed the transaction (the "Transaction") by which it acquired Mylan Inc. and Abbott Laboratories' ("Abbott") non-U.S. developed markets specialty and branded generics business (the "Business"). Pursuant to the terms of the Amended and Restated Business Transfer Agreement and Plan of Merger, dated as of November 4, 2014, by and among Mylan Inc., New Moon B.V. (which has been renamed Mylan N.V. and is referred to herein as "Mylan"), Moon of PA Inc. ("Merger Sub"), and Abbott, on the Closing Date, Mylan acquired the Business and Merger Sub merged with and into Mylan Inc., with Mylan Inc. surviving as a wholly owned indirect subsidiary of Mylan and each share of Mylan Inc. common stock issued and outstanding was cancelled and automatically converted into and became the right to receive one Mylan ordinary share (the "Merger"). (Continued in Footnote 2)
- [F10]These options vested in full on May 28, 2014.
- [F11]These options will vest in full on April 11, 2015.
- [F2]In connection with the Transaction, Mylan Inc. and the Business have been reorganized under Mylan, a new public company organized in the Netherlands. This report is being filed by the reporting person solely to report the disposition of shares of Mylan Inc. common stock in connection with the Transaction. The reporting person will file a separate Form 4 to reflect the corresponding acquisition of securities of Mylan in connection with the Transaction.
- [F3]Represents shares of Mylan Inc. common stock that were exchanged on a one-for-one basis for Mylan ordinary shares in connection with the Transaction. On the effective date of the Merger, the closing price of MYL was $57.33 per share.
- [F4]Represents stock options of Mylan Inc. common stock that were exchanged for stock options of Mylan ordinary shares having substantially the same terms in connection with the Transaction.
- [F5]These options vested in full on April 25, 2009.
- [F6]These options vested in full on May 7, 2010.
- [F7]These options vested in full on May 14, 2011.
- [F8]These options vested in full on May 6, 2012.
- [F9]These options vested in full on May 4, 2013.
Documents
Issuer
MYLAN INC.
CIK 0000069499
Entity typeoperating
IncorporatedPA
Related Parties
1- filerCIK 0000069499
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 6:40 PM ET
- Size
- 22.9 KB